510(k) K152328
K152328 is an FDA 510(k) premarket notification submitted by Abott Laboratories for the device "FreeStyle InsuLinx Blood Glucose Monotioring System". The FDA issued a decision of Substantially Equivalent on September 17, 2015. The device falls under product code LFR (Glucose Dehydrogenase, Glucose), a Class II device regulated under 21 CFR 862.1345.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 17, 2015
- Date Received
- August 18, 2015
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Glucose Dehydrogenase, Glucose
- Device Class
- Class II
- Regulation Number
- 862.1345
- Review Panel
- CH
- Submission Type